Neurotech startup RehabVeda featured on Shark Tank India, where founders Shyam Parmar and Neel Patel pitched their innovative solution designed to improve brain-hand connection for stroke recovery.
During the pitch, the founders highlighted that India records 18 lakh new brain stroke cases annually. Standard neuro-rehabilitation monthly costs can start at ₹2 lakhs, making long-term care inaccessible for many.
RehabVeda addresses this with their R1 Kit, a home-use neurofeedback system that requires no professional supervision. The innovation centers on a 2-sensor EEG system featuring a headband with gold-plated dry sensors and ear clip sensors, paired with an AI interface. While traditional neurofeedback systems can cost between ₹50 lakhs to ₹1 crore, RehabVeda offers their B2B solution at ₹2 lakhs and an at-home 4-month subscription for ₹60,000.
Entering the Tank, the founders sought ₹1 crore for 2.5% equity, valuing the company at ₹40 crores.
Product development began in December 2024, and the company has already secured a CDSCO test license and filed for a patent. Their go-to-market strategy is a B2B2C model driven by doctor referrals; they have already onboarded 5 doctors, including three neurologists and two physiotherapists. The R1 Kit boasts an 89% B2B gross margin with a COGS of Rs 22,000. To date, the founders have supported a lifetime of 70+ patients.
The therapy protocol involves 30–45 minute sessions performed twice daily. Initial signs of recovery are typically observed within 3–4 weeks, with complete recovery depending on severity taking between 4–6 months. The at-home subscription includes a personalized therapy plan and weekly progress tracking.
After discussions, Namita Thapar and Mohit Yadav closed the deal by investing ₹1 crore for 3% equity, valuing RehabVeda at ₹33.33 crores.
The founders shared that the capital raised will be used to further their mission of making advanced neuro-rehabilitation affordable and accessible, transitioning stroke recovery from expensive clinical settings to the comfort of the patient’s home.
